On September 9, 2024 the Bioman4R2 webinar "Regulatory Insight; Introduction combination product development." took place.
This was part of our peer learning activities and our mission to contribute to a more resilient biomanufacturing & medtech EU cluster.
Thank you to all 50 participants for joining us!
Below you find the slides presented by the experts. Their contact details can also be found in the PDFs and do feel free to contact them in case you have more in depth questions!
About BioMan4R2
The BioMan4R2 project within the European SMP COSME program offers financial support and networking for small and medium-sized companies in the biological products and medical technology manufacturing sectors that want to increase their resilience, sustainability and competitiveness.
The partner regions in Europe for this project, together with LifetecZONe are Turku Science Park Oy Ab (FI), Bioregio STERN (DE), Medicen Paris Region (FR), GAPR the Upper Silesian Accelerator for Commercial Enterprises Ltd (PL), Council of European Bioregions and Biocat (ES).
To this end, the BioMan4R2 project has offered financial support and networking under the European SMP COSME program for small and medium-sized enterprises in the biomanufacturing and medical technology (BMT) sectors that want to increase their resilience, sustainability and competitiveness.
Further information
Visit the BioMan4R2 project on the European Cluster Collaboration Platform (ECCP) for up-to-date information on activities.
And follow Bioman4R2 on LinkedIn and stay up to date on new opportunities!
For more information, mail projectmanager Ingrid Relou.
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or EISMEA. Neither the European Union nor the granting authority can be held responsible for them.
Announcement of the 26 grant winners
In April 2023, the call for applications was launched to make European ecosystems more sustainable and resilient for the future within the BioMan4R2 Eurocluster. The call closed in July 2023 and we received 118 excellent applications from different European countries.
We are pleased to announce today that 26 companies best suited for the program have been selected. The selected companies will receive an official letter of approval for the program in the next few days.
For those who were not successful this time, we recommend taking a look at the Euroclusters | European Cluster Collaboration Platform. Several open calls for proposals on different topics are published here.
The applications were, ranked based on average scores for impact, implementation, and excellence criteria. The impact section held the highest weight, followed by implementation and excellence. The successful Bioman4R2 Eurocluster project applications outperformed the unsuccessful applications based on several key factors. Winners in the Business Transformation and Innovation Financial Support categories excelled by providing detailed budget allocations, a robust team involved in the implementation, and proven expertise in Biomanufacturing and MedTech. Clear ambition, comprehensive team descriptions, and aligned budgets with Key Performance Indicators (KPIs) were crucial for Innovation project success specifically. Successful applicants showcased a strong impact focus, demonstrating their commitment and solid approach to achieving positive outcomes and impact in the Biomanufacturing and MedTech sector and beyond.
Some winning applications requested less funding than expected, which allowed for an additional project to be partially funded. This presented an opportunity to support an extra project and maximize the impact of the Financial Support Scheme.